• If you are wondering whether MetLife at around US$80.23 is offering fair value or reflects a potential mismatch between price and business quality, this breakdown will help you frame that question clearly.
• The stock has returned 3.3% over the last 7 days and 12.7% over the last 30 days, with a 1 year return of 6.2% and a 3 year return of 61.1%.
• Recent news around MetLife has focused on its positioning within the wider US insurance sector and how its scale and product mix compare to peers. These updates give context for why investors may be reassessing both risk and growth potential even though the year to date return is around a 0.1% decline.
• On Simply Wall St's 6 point valuation framework, MetLife currently has a value score of 2. The sections that follow walk through the main valuation methods behind that score and suggest a broader way to think about value that ties everything together by the end of the article.

MetLife scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: MetLife Excess Returns Analysis

The Excess Returns model evaluates how much profit a company is expected to generate above the return that equity investors require, and then capitalizes those extra profits into an intrinsic value per share.

For MetLife, the starting point is an estimated Book Value of $43.33 per share and a Stable EPS of $8.62 per share, based on weighted future Return on Equity estimates from 8 analysts. The average Return on Equity is 15.85%, compared with a Cost of Equity of $4.33 per share, which implies an Excess Return of $4.29 per share. In simple terms, the model assumes MetLife can earn more on its equity base than investors require.

The analysis also uses a Stable Book Value estimate of $54.39 per share, sourced from weighted future Book Value estimates from 6 analysts, to project how those excess returns build over time. Combining these inputs, the Excess Returns valuation produces an intrinsic value of about $148.44 per share, which indicates the stock is 46.0% undervalued relative to a share price around $80.23.

Result: UNDERVALUED

Our Excess Returns analysis suggests MetLife is undervalued by 46.0%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: MetLife Price vs Earnings

P/E is a common way to value profitable companies because it links what you pay for each share to the earnings that support that share. It gives you a quick sense of how many dollars of price you are paying for each dollar of current earnings.

What counts as a “normal” or “fair” P/E ratio usually reflects how the market views a company’s growth prospects and risks. Higher expected growth or lower perceived risk can support a higher P/E, while lower growth or higher risk tends to go with a lower P/E.

MetLife currently trades on a P/E of 16.31x. This compares with an Insurance industry average P/E of 11.72x and a peer group average of 13.21x. Simply Wall St’s Fair Ratio for MetLife, which is 14.55x, is a proprietary estimate of what P/E might make sense given factors such as earnings growth, profit margins, industry, market cap and company specific risks.

Because the Fair Ratio incorporates these fundamentals directly, it can be more informative than a simple comparison with peers or the broader industry.

With the actual P/E of 16.31x sitting above the Fair Ratio of 14.55x by more than 0.10, the stock screens as overvalued on this metric alone.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your MetLife Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced here as your chance to attach a clear story about MetLife to your own numbers. This links a view on its future revenue, earnings and margins to a forecast and then to a fair value that you can compare with today’s price inside Simply Wall St’s Community page. Different users may, for example, see MetLife as a high conviction opportunity with a fair value closer to the upper analyst target of US$102.00, or as a more cautious case anchored near US$75.00. As news, earnings or guidance change, those Narratives and their fair values update automatically so you can more easily judge whether the current price gives you enough margin between what you think MetLife is worth and where it is trading.

Do you think there's more to the story for MetLife? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.